vs
INTERGROUP CORP（INTG）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是INTERGROUP CORP的1.1倍（$19.6M vs $17.3M），INTERGROUP CORP净利率更高（8.8% vs -177.4%，领先186.2%），INTERGROUP CORP同比增速更快（19.8% vs -11.5%），INTERGROUP CORP自由现金流更多（$-481.0K vs $-23.1M），过去两年INTERGROUP CORP的营收复合增速更高（7.8% vs -12.2%）
Intergroup Corp是一家多元化控股企业，核心业务覆盖房地产与酒店运营两大板块。公司在美国境内持有、管理及租赁商住类物业，同时运营面向休闲和商务旅客的有限服务型酒店。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
INTG vs LAB — 直观对比
营收规模更大
LAB
是对方的1.1倍
$17.3M
营收增速更快
INTG
高出31.3%
-11.5%
净利率更高
INTG
高出186.2%
-177.4%
自由现金流更多
INTG
多$22.6M
$-23.1M
两年增速更快
INTG
近两年复合增速
-12.2%
损益表 — Q2 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $17.3M | $19.6M |
| 净利润 | $1.5M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | 11.6% | -168.5% |
| 净利率 | 8.8% | -177.4% |
| 营收同比 | 19.8% | -11.5% |
| 净利润同比 | 155.6% | -28.8% |
| 每股收益（稀释后） | $0.71 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INTGLAB
| Q4 25 | $17.3M | — | ||
| Q3 25 | $17.9M | $19.6M | ||
| Q2 25 | $16.2M | $21.8M | ||
| Q1 25 | $16.8M | $40.8M | ||
| Q4 24 | $14.4M | — | ||
| Q3 24 | $16.9M | $22.1M | ||
| Q2 24 | $13.4M | $22.5M | ||
| Q1 24 | $14.9M | $45.5M |
净利润INTGLAB
| Q4 25 | $1.5M | — | ||
| Q3 25 | $-535.0K | $-34.7M | ||
| Q2 25 | $-2.2M | $-33.5M | ||
| Q1 25 | $-578.0K | $-26.0M | ||
| Q4 24 | $-2.7M | — | ||
| Q3 24 | $-398.0K | $-26.9M | ||
| Q2 24 | $-4.9M | $-45.7M | ||
| Q1 24 | $-3.2M | $-32.2M |
毛利率INTGLAB
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
营业利润率INTGLAB
| Q4 25 | 11.6% | — | ||
| Q3 25 | 15.3% | -168.5% | ||
| Q2 25 | 8.1% | -118.1% | ||
| Q1 25 | 14.0% | -80.8% | ||
| Q4 24 | 5.9% | — | ||
| Q3 24 | 18.5% | -120.9% | ||
| Q2 24 | 3.7% | -134.5% | ||
| Q1 24 | 4.8% | -132.2% |
净利率INTGLAB
| Q4 25 | 8.8% | — | ||
| Q3 25 | -3.0% | -177.4% | ||
| Q2 25 | -13.9% | -153.7% | ||
| Q1 25 | -3.4% | -63.8% | ||
| Q4 24 | -18.9% | — | ||
| Q3 24 | -2.4% | -122.0% | ||
| Q2 24 | -36.7% | -203.3% | ||
| Q1 24 | -21.3% | -70.6% |
每股收益（稀释后）INTGLAB
| Q4 25 | $0.71 | — | ||
| Q3 25 | $-0.25 | $-0.09 | ||
| Q2 25 | — | $-0.09 | ||
| Q1 25 | $-0.27 | $-0.07 | ||
| Q4 24 | $-1.26 | — | ||
| Q3 24 | $-0.18 | $-0.07 | ||
| Q2 24 | — | $-0.12 | ||
| Q1 24 | $-1.44 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $7.5M | $129.4M |
| 总债务越低越好 | $233.2M | — |
| 股东权益账面价值 | $-85.2M | $399.7M |
| 总资产 | $101.1M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资INTGLAB
| Q4 25 | $7.5M | — | ||
| Q3 25 | $6.0M | $129.4M | ||
| Q2 25 | $6.1M | $158.6M | ||
| Q1 25 | $4.8M | $150.9M | ||
| Q4 24 | $15.4M | — | ||
| Q3 24 | $12.2M | $210.6M | ||
| Q2 24 | $11.6M | $269.8M | ||
| Q1 24 | $19.5M | $287.1M |
总债务INTGLAB
| Q4 25 | $233.2M | — | ||
| Q3 25 | $237.8M | — | ||
| Q2 25 | $240.5M | — | ||
| Q1 25 | $241.5M | — | ||
| Q4 24 | $227.2M | — | ||
| Q3 24 | $218.1M | $55.2M | ||
| Q2 24 | $225.7M | $55.1M | ||
| Q1 24 | $225.0M | $55.0M |
股东权益INTGLAB
| Q4 25 | $-85.2M | — | ||
| Q3 25 | $-86.7M | $399.7M | ||
| Q2 25 | $-86.1M | $424.5M | ||
| Q1 25 | $-84.5M | $454.6M | ||
| Q4 24 | $-83.9M | — | ||
| Q3 24 | $-80.9M | $489.3M | ||
| Q2 24 | $-80.3M | $510.3M | ||
| Q1 24 | $-76.4M | $577.3M |
总资产INTGLAB
| Q4 25 | $101.1M | — | ||
| Q3 25 | $102.5M | $539.6M | ||
| Q2 25 | $104.1M | $557.0M | ||
| Q1 25 | $103.2M | $579.6M | ||
| Q4 24 | $110.6M | — | ||
| Q3 24 | $109.3M | $681.5M | ||
| Q2 24 | $107.8M | $708.7M | ||
| Q1 24 | $119.0M | $777.7M |
负债/权益比INTGLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-23.0K | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $-481.0K | $-23.1M |
| 自由现金流率自由现金流/营收 | -2.8% | -118.1% |
| 资本支出强度资本支出/营收 | 2.6% | 4.5% |
| 现金转化率经营现金流/净利润 | -0.02× | — |
| 过去12个月自由现金流最近4个季度 | $739.0K | $-111.1M |
8季度趋势，按日历期对齐
经营现金流INTGLAB
| Q4 25 | $-23.0K | — | ||
| Q3 25 | $-296.0K | $-22.2M | ||
| Q2 25 | $5.9M | $-20.7M | ||
| Q1 25 | $-854.0K | $-30.3M | ||
| Q4 24 | $-781.0K | — | ||
| Q3 24 | $3.4M | $-27.9M | ||
| Q2 24 | $6.8M | $-39.0M | ||
| Q1 24 | $1.9M | $-62.5M |
自由现金流INTGLAB
| Q4 25 | $-481.0K | — | ||
| Q3 25 | $-1.3M | $-23.1M | ||
| Q2 25 | $3.6M | $-22.6M | ||
| Q1 25 | $-1.2M | $-35.3M | ||
| Q4 24 | $-1.1M | — | ||
| Q3 24 | $3.1M | $-30.1M | ||
| Q2 24 | $2.7M | $-41.0M | ||
| Q1 24 | $1.1M | $-63.3M |
自由现金流率INTGLAB
| Q4 25 | -2.8% | — | ||
| Q3 25 | -7.1% | -118.1% | ||
| Q2 25 | 22.5% | -103.6% | ||
| Q1 25 | -6.8% | -86.6% | ||
| Q4 24 | -7.8% | — | ||
| Q3 24 | 18.3% | -136.4% | ||
| Q2 24 | 20.4% | -182.2% | ||
| Q1 24 | 7.6% | -138.9% |
资本支出强度INTGLAB
| Q4 25 | 2.6% | — | ||
| Q3 25 | 5.4% | 4.5% | ||
| Q2 25 | 13.9% | 8.7% | ||
| Q1 25 | 1.8% | 12.4% | ||
| Q4 24 | 2.4% | — | ||
| Q3 24 | 1.6% | 10.2% | ||
| Q2 24 | 30.4% | 8.6% | ||
| Q1 24 | 4.9% | 1.7% |
现金转化率INTGLAB
| Q4 25 | -0.02× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INTG
| Hotel Operations | $12.7M | 73% |
| Real Estate Operation | $4.6M | 27% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
